Staging and Prognostic Factors Committee

Staging lung cancer and other thoracic malignancies accurately is critical in deciding treatment regimens and ensures best standardized care for patients worldwide. The IASLC Staging Project is a global effort to study and improve the current staging system for lung cancer, as well as for thymic and esophageal cancers and mesothelioma.
Committees_Meso_NEW BANNER_podium Rusch

Overview

Over the past two decades, the IASLC Staging Project has produced a steady stream of evidence-based recommendations for the TNM Classification for Thoracic Cancers, published by "Union for International Cancer Control (UICC) and the American Joint Council on Cancer (AJCC)". The project is now entering the third cycle, with the goal of developing recommendations for the 9th edition of TNM. Staging lung cancer and other thoracic malignancies accurately is critical in deciding treatment regimens and ensures best standardized care for patients worldwide. New data elements such as genetic biomarkers, protein alterations and copy number alterations will be added to the staging project for the first time, and such additions and enhancements to the system may significantly improve the current staging system, leading to more precise treatment decisions and improvement in patient survival.

Chair of Committee

Hiaso Profile Image
Hisao Asamura
2019 to present
"The Staging Laminate Reference Cards, 8th Edition, are the perfect size to be kept in the pockets of a white coat or surgical suit for a quick reference to the different categories of the three components of anatomic extent of lung cancer. These are very popular among those involved with the management of thoracic malignancies."

Thank you for submitting to the 9th Edition

The IASLC is grateful to its members and other thoracic oncology professionals who submitted  patient data to better inform the 9th Edition of the TNM Classification for Thoracic Cancers. As the data collection window for the 9th Edition is now closed, the IASLC encourages early applications to the 10th Edition of TNM Classification for Thoracic Cancers. Check back often as more information will become available. 

 

Roster

Hisao Asamura
Japan
Keio University School of Medicine
Committee Chair
Valerie Rusch
United States
Memorial Sloan-Kettering Cancer Center
Chair-Elect
Paul Van Schil
Belgium
University Hospital of Antwerp
Board Liaison
Murry Wynes
United States
International Association for the Study of Lung Cancer
Staff Liaison
David Beer
United States
University of Michigan
Committee Member
Xavier Benoit D'Journo
France
Hôpital Nord - Aix-Marseille University
Committee Member
Pietro Bertoglio
Italy
Sacro Cuore - Don Calabria Research Hospital
Committee Member
Ricardo Beyruti
Brazil
University of Sao Paulo Medical School
Committee Member
Andrea Bille
United Kingdom
Guy's Hospital
Committee Member
Souheil Boubia
Morocco
University Hospital IBN Rochd Casablanca
Committee Member
Elisabeth Brambilla
France
CHU Albert Michallon
Emeritus Member
James Brierley
Canada
University Health Network
Committee Member
David Paul Carbone
United States
Ohio State University
Committee Member
Ayten Cangir
Turkey
Ankara University
Committee Member
Giuseppe Cardillo
Italy
Azienda Ospedaliera San Camillo Forianini
Committee Member
Gail Darling
Canada
University of Toronto
Committee Member
Elizabeth David
United States
University of California, Davis
Committee Member
Luiz Henrique de Lima Araujo
Brazil
Instituto Nacional de Cancerlogia de Mexico
Committee Member
Marc de Perrot
Canada
University Health Network
Committee Member
Frank Detterbeck
United States
Yale University School of Medicine
Committee Member
Jessica Donington
United States
University of Chicago
Committee Member
Wilfried Eberhardt
Germany
University of Essen
Committee Member
John Edwards
United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust
Committee Member
Jeremy John Erasmus
United States
MD Anderson Cancer Center
Committee Member
Wentao Fang
China
Shanghai Chest Hospital
Committee Member
Dean Fennell
United Kingdom
University of Leicester and Leicester University Hospitals
Committee Member
Pier Luigi Filosso
Italy
University of Torino
Committee Member
Kwun Fong
Australia
The Prince Charles Hospital / University of Queensland Thoracic Research Center
Committee Member
Francoise Galateau-Salle
France
Centre Leon Berard
Committee Member
Oliver Gautschi
Switzerland
Luzerner Kantonsspital
Committee Member
Ritu Gill
United States
Beth Israel Deaconess Medical Center
Committee Member
Nicolas Girard
France
Institut Curie
Committee Member
Seiki Hasegawa
Japan
Hyogo College of Medicine
Committee Member
Fred Hirsch
United States
University of Colorado Cancer Center
Committee Member
Hans Hoffmann
Germany
Technical University of Munich
Committee Member
Wayne Hofstetter
United States
MD Anderson Cancer Center
Committee Member
James Huang
United States
Memorial Sloan-Kettering Cancer Center
Committee Member
Mauricio Infante
Italy
Azienda Ospedaliera Universitaria Integrata Verona
Proposed Committee Member
Liyan Jiang
China
Shanghai Chest Hospital
Committee Member
Kemp Kernstine
United States
University of Texas Southwestern Medical Center
Committee Member
Keith Kerr
United Kingdom
University of Aberdeen, School of Medicine and Dentistry
Committee Member
Hedy Lee Kindler
United States
The University of Chicago Medical Center
Committee Member
Kazuya Kondo
Japan
The University of Tokushima
Committee Member
Kaoru Kubota
Japan
Nippon Medical School
Committee Member
Hong Kwan Kim
South Korea
Samsung Medical Center, Sungkyunkwan Univerisity School of Medicine
Committee Member
Yolande Lievens
Belgium
UZ Ghent
Committee Member
Eric Lim
United Kingdom
Royal Brompton Hospital
Committee Member
Hui Liu
China
Sun Yat-Sen University Cancer Center
Committee Member
Donald Low
United States
Virginia Mason Medical Center
Committee Member
Gustavo Lyons
Argentina
Buenos Aires British Hospital
Committee Member
Heber MacMahon
United States
The University of Chicago
Committee Member
Mirella Marino
Italy
Regina Elena Cancer Institute of Rome
Committee Member
Edith M. Marom
Israel
The Chaim Sheba Medical Center
Committee Member
Clarissa Mathias
Brazil
Nucleo de Oncologia da Bahia
Committee Member
José Matilla
Spain
University Clinic Hospital of Valladolid
Committee Member
Jin Mo Goo
South Korea
Seoul National University Hospital
Committee Member
Luis Montuenga
Spain
Fundacion Investigacion Medica Aplicada (FIMA)
Committee Member
Jun Nakajima
Japan
University of Tokyo
Committee Member
Andrew Nicholson
United Kingdom
Royal Brompton and Harefield NHS Foundation Trust
Committee Member
Anna Nowak
Australia
University of Western Australia
Committee Member
Meinoshin Okumura
Japan
Toneyama National Hospital
Committee Member
Isabelle Opitz
Switzerland
University Hospital Zurich
Committee Member
Ray Osarogiagbon
United States
Baptist Cancer Center
Committee Member
Marcin Ostrowski
Poland
Medical University of Gdansk
Proposed Committee Member
Harvey Pass
United States
NYU Langone Medical Center
Committee Member
Helmut Prosch
Austria
Medical University of Vienna
Committee Member
Paul Martin Putora
Switzerland
Kantonsspital St. Gallen
Committee Member
Ramón Rami-Porta
Spain
Hospital Universitari Mutua Terrassa
Committee Member
David Rice
United States
MD Anderson Cancer Center
Committee Member
Thomas Rice
United States
Cleveland Clinic Foundation
Committee Member
Andreas Rimner
United States
Memorial Sloan-Kettering Cancer Center
Committee Member
Enrico Ruffini
Italy
University of Torino
Committee Member
Shuji Sakai
Japan
Tokyo Women's Medical University
Committee Member
Navneet Singh
India
PGIMER
Committee Member
Francisco Suarez
Chile
Clinica Santa Maria
Committee Member
Young Tae Kim
South Korea
Seoul National University
Committee Member
Ricardo Terra
Brazil
University of Sao Paulo Medical School
Committee Member
Ming Tsao
Canada
Princess Margaret Hospital
Committee Member
William Travis
United States
Memorial Sloan-Kettering Cancer Center
Committee Member
Akif Turna
Turkey
Istanbul University Cerrahpasa Medical School
Committee Member
Paula Ugalde
United States
Brigham & Women's Hospital
Board Liaison
Jan Van Meerbeeck
Belgium
Antwerp University Hospital & Erasmus MC
Committee Member
David Waller
United Kingdom
Barts Thorax Centre, Barts Health NHS Trust
Observer
Shun-Ichi Watanabe
Japan
National Cancer Center Hospital & Research Institute.
Committee Member
Ignacio Wistuba
United States
MD Anderson Cancer Center
Committee Member
Yasushi Yatabe
Japan
Aichi Cancer Center Hospital
Committee Member

Related Resources

Data Elements - 9th edition of the Staging Project.
Staging Project Resource
Specific data elements are required to participate in the Staging Project. Use this resource as your...
Download(2.43 MB)
Image for 8th edition slides for IASLC web site
Staging Project Resource
8th Edition of the TNM Classification System Slides
Download(1.94 MB)
IASLC_2020_Staging_Toolkit_Full_F4_Cover
Staging Project Resource
The Staging Project is now entering the third cycle, with the goal of developing recommendations for...
Download(4.37 MB)
Poster 8th Edition TNM Classification of Lung Nonmucinous AIS MIA and Lepidic Predominant Adenocarcinoma Poster
Staging Project Resource
The posters of the TNM and of the pathologic details of the newcomers into the TNM system (AIS, MIA...
Poster 8th Edition Lung Cancer TNM Staging Summary Poster
Staging Project Resource
The posters of the TNM and of the pathologic details of the newcomers into the TNM system (AIS, MIA...
Annual Report 2020
Staging Project Resource
The IASLC Staging and Prognostic Factors Committee (SPFC) proposed revisions to the lung cancer...
Staging Laminate Reference Cards, 8th Edition Cover
Staging Project Resource
The Staging Laminate Reference Cards, 8th Edition, are the perfect size to be kept in the pockets of...
GDPR-Combined-DUA_New-1-Image
Staging Project Resource
Anyone interested in submitting data for the 9th Edition of the Staging Project must submit a...
Download(191.39 KB)
Call for Participation
Staging Project Resource
Fill out this form to participate in the data submission process for the 9th Edition of the Staging...
Download(236.81 KB)
(IASLC) Staging Project In Malignant Pleural Mesothelioma
Staging Project Resource
The Protocol for the Staging Project in MPM is a fundamental tool for those who intend to apply for...
Download(535.37 KB)
(IASLC) Staging Project In Malignant Pleural Mesothelioma
Staging Project Resource
A contractual overview of the MPM portion of the Staging Project.
Download(346.7 KB)
IASLC Malignant Pleural Mesothelioma Staging Project, Data Elements
Staging Project Resource
Specific data elements are required to participate in the Staging Project. This document outlines...
Download(1.15 MB)
Submit Data for the 9th Edition -- IASLC 2009 Nodal Map
Staging Project Resource
Detailed full-color map of the mediastinal, aortic, and N1 nodes.
Download(543.51 KB)
Submit Data for the 9th Edition -- Definitions for T, N, and M, Descriptors
Staging Project Resource
TNM definitions used in the 8th Edition of the Staging Project.
Download(79.22 KB)
Submit Data for the 9th Edition -- Protocol Document
Staging Project Resource
The Protocol is a fundamental tool for those who intend to apply for grants to enable their...
Download(335.98 KB)

IASLC International Staging Project Data Query Application (8th Edition)

Access to the combined dataset is restricted, however, an investigator may propose a research question for analysis. Such analyses are done collaboratively by CRAB, the IASLC SPFC, and the requestor. An investigator with a research question will complete an initial form outlining the question and the proposed data requirements.

To submit a project proposal please complete the form linked here.

Based on the proposal, feasibility will be determined and a cost will be determined for the analysis effort. Once it is determined to be feasible, the research question will be submitted for approval to the SPFC and the IASLC.

Submit Staging Project Data More Quickly and Efficiently

You must apply to the Staging Project and receive approval prior to being able to access the data submission tools. Once you have been notified about acceptance, use the helpful resources and documents provided on this page—especially the Toolkit—to navigate data submission.

Protocol Document

Staging_protocol

Allows for data standardization while maintaining compliance and patient privacy

Staging Toolkit

Staging_NodalMap

This resource explains the data requirements and submission process and allows for easy formatting for grants.

Account Change Form

Staging Project Database Account Change Form

Please use this form to update your account information.

Mesothelioma Staging

The IASLC Staging Project in Malignant Pleural Mesothelioma is an offshoot of the Staging Project. This project is a global effort to study and improve the current staging system specific to mesothelioma. All of the same resources apply regarding submission of data. The Mesothelioma Domain is seeking data on patients with malignant pleural mesothelioma who were diagnosed between July 1, 2013 and December 31, 2020. The deadline for data submission is December 31, 2021.

Data Elements Specific to Mesothelioma

Committees_Staging_Meso data.jpg

Download the data elements specific to mesothelioma

Protocol Specific to Mesothelioma

Committees_Staging_Meso Protocol

View the protocol specific to mesothelioma

Explore JTO Collections

Image
s

Advanced Radiation Technology (ART) Committee

Browse editorials and white papers by the ART Committee members regarding clinical standards and questions
Image
s

Early Detection & Screening

Read the JTO Collection for screening information, from detection of incidental nodules to novel LDCT data.
Image
a

Mesothelioma Collection

The latest in mesothelioma patient care and research, as published in the JTO.
Image
Scientist Testing in Lab

Pathology

Stay abreast of the latest testing techniques and applications, as published in the JTO.